P
Paul Cleary
Researcher at Public Health England
Publications - 49
Citations - 2152
Paul Cleary is an academic researcher from Public Health England. The author has contributed to research in topics: Outbreak & Population. The author has an hindex of 16, co-authored 47 publications receiving 1815 citations. Previous affiliations of Paul Cleary include University of Malawi & University of Manchester.
Papers
More filters
Journal ArticleDOI
The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis
John Mair-Jenkins,Maria Saavedra-Campos,J Kenneth Baillie,Paul Cleary,Fu-Meng Khaw,Wei Shen Lim,Sophia Makki,Kevin Rooney,Jonathan S. Nguyen-Van-Tam,Charles R. Beck,Ana Mateus,Simone Reuter,Jinho Shin,Xiaolin Xu,Dmitriy Pereyaslov,Irina Papieva,Anders Tegnell,Hélène Englund,Åsa Elfving,Rebecca Jane Cox,Kristin G.-I. Mohn,Yingjie Feng Jenkins +21 more
TL;DR: Convalescent plasma may reduce mortality and appears safe, and should be studied within the context of a well-designed clinical trial or other formal evaluation, including for treatment of Middle East respiratory syndrome coronavirus CoV infection.
Journal ArticleDOI
Late-onset seizures as a predictor of subsequent stroke.
TL;DR: The findings show that the onset of seizures in late life is associated with a striking increase in the risk of stroke.
Journal ArticleDOI
Evaluation of antiretroviral therapy results in a resource-poor setting in Blantyre, Malawi.
Joep J. van Oosterhout,Neena Bodasing,Johnstone Kumwenda,Cooper Nyirenda,Jane Mallewa,Paul Cleary,Michel P. de Baar,Rob Schuurman,David M. Burger,Eduard E. Zijlstra +9 more
TL;DR: Evaluated treatment results of the paying antiretroviral therapy (ART) clinic of Queen Elizabeth Central Hospital, a large public and teaching hospital in Blantyre, Malawi found the only ART was a fixed drug combination of stavudine, lamivudine and nevirapine.
Journal ArticleDOI
Pandemic Influenza A (H1N1) 2009 and mortality in the United Kingdom: risk factors for death, April 2009 to March 2010.
Richard Pebody,Estelle McLean,Hongxin Zhao,Paul Cleary,S. Bracebridge,Kirsty Foster,Andre Charlett,Pia Hardelid,Pauline Waight,Joanna Ellis,Alison Bermingham,Maria Zambon,Barry Evans,Roland L. Salmon,Jim McMenamin,B. Smyth,Mike Catchpole,John M Watson +17 more
TL;DR: The epidemiology of fatal pandemic influenza A(H1N1) cases in the United Kingdom since April 2009 and in particular risk factors associated with death are described and the importance of early targeted effective intervention programmes is highlighted.
Journal ArticleDOI
Extended-spectrum β-lactamase-producing Escherichia coli in human-derived and foodchain-derived samples from England, Wales, and Scotland: an epidemiological surveillance and typing study
Michaela Day,Katie L. Hopkins,David W. Wareham,Mark Toleman,Nicola Elviss,Luke P. Randall,Christopher Teale,Paul Cleary,Camilla Wiuff,Michel Doumith,Matthew J. Ellington,Neil Woodford,David M. Livermore,David M. Livermore +13 more
TL;DR: Most human bacteraemias with ESBL-E coli in the UK involve internationally prevalent human-associated STs, particularly ST131; non-human reservoirs made little contribution to invasive human disease.